Learn about chalazion diagnosis, including clinical documentation and medical coding for meibomian cyst or tarsal cyst. Find information on chalazion treatment, ICD-10 codes, and differential diagnosis. This resource provides healthcare professionals with key details for accurate chalazion identification and management in medical records.
A small, usually painless bump or swelling on the eyelid, caused by a blocked oil gland.
Eyelid swelling, redness, tenderness, sometimes blurred vision if large.
Primary care, ophthalmology, optometry clinics.
Complete code families applicable to H00.19
| Description | When to use |
|---|---|
| Small eyelid cyst, usually painless. | Use for localized, non-infectious swelling on eyelid. Rule out stye. |
| Infected eyelash follicle, painful. | Use for red, painful, pus-filled bump on eyelid margin. Often external hordeolum. |
| Inflammation of meibomian gland within eyelid. | Use for tender, red swelling inside the eyelid. Consider internal hordeolum. |
Missing or incorrect laterality (right, left, bilateral) for chalazion diagnosis impacts reimbursement and data accuracy. Important for medical coding and CDI.
Confusing chalazion (C42.1) with hordeolum/stye (H00.0) leads to inaccurate coding and potential claim denials. Requires careful clinical documentation review.
Using unspecified codes like H00.1 when a more specific chalazion code (C42.1) is applicable can trigger audits and affect quality metrics. CDI specialist review needed.
Confirm localized, painless eyelid swelling
Rule out infection: No pain, warmth, or erythema
Palpate for firm, non-tender nodule
Document size and location for accurate coding
Patient presents with a chalazion, also known as a meibomian cyst or tarsal cyst, a common eyelid lump. Examination reveals a localized, non-tender, firm swelling on the [upper/lower] eyelid, consistent with a blocked meibomian gland. The patient reports [asymptomatic/mild discomfort/pressure/eyelid redness/blurry vision if large enough to distort the cornea]. The lesion is [size in mm] and located [location on eyelid]. No signs of infection, such as eyelid cellulitis or preseptal cellulitis, are observed. Differential diagnosis includes hordeolum (stye), inclusion cyst, and other eyelid neoplasms, though the presentation is most consistent with chalazion. Treatment plan includes conservative management with warm compresses applied to the affected eyelid for 10-15 minutes, four times daily. Patient education provided on proper eyelid hygiene including lid scrubs. Follow-up scheduled in [timeframe] to assess response to treatment. If the chalazion persists or enlarges, further intervention such as incision and curettage or steroid injection may be considered. ICD-10 code H00.1 (chalazion) is documented.
While both chalazia and hordeola present as eyelid lumps, several key clinical features aid in differentiation. A chalazion, also known as a meibomian cyst or tarsal cyst, typically develops as a painless, slow-growing, firm nodule within the tarsal plate. It results from chronic inflammation and obstruction of a meibomian gland, leading to lipogranulomatous inflammation. In contrast, a hordeolum, or stye, presents as a tender, erythematous, localized swelling, often near the eyelash follicle (external hordeolum) or within the meibomian gland (internal hordeolum) and is typically caused by an acute bacterial infection. The pain level, rate of onset, and location are crucial factors in distinguishing between these conditions. Consider implementing a thorough examination, including palpation and eversion of the eyelid, to aid in accurate diagnosis. Explore how combining clinical presentation with patient history can further enhance diagnostic accuracy and guide treatment decisions.
Conservative treatment for a chalazion, including warm compresses, lid hygiene, and topical antibiotics or corticosteroids, is often effective. However, surgical intervention is indicated when a chalazion persists for several weeks despite conservative management, causes significant cosmetic concerns, or impairs vision. Best surgical approaches for chalazion removal prioritize minimizing recurrence and optimizing cosmetic outcomes. These include incision and curettage (I&C), performed through either a transconjunctival or transcutaneous approach depending on chalazion location and size, and steroid injection, which can be particularly effective for smaller, non-fibrotic lesions. I&C offers thorough removal of the granulomatous material, whereas steroid injection provides a less invasive option for suitable candidates. Learn more about the various surgical techniques and factors influencing surgical decision-making to ensure optimal patient outcomes. Explore how incorporating post-operative care instructions, such as continued warm compresses and eyelid hygiene, can further minimize recurrence rates.
While warm compresses are the cornerstone of conservative chalazion management, several additional evidence-based strategies can enhance treatment efficacy. Topical antibiotic or corticosteroid ointments can be beneficial, particularly in cases with associated blepharitis or suspected secondary infection. Systemic antibiotics may be considered in cases of severe or recurrent chalazion with suspected systemic involvement. Furthermore, lid hygiene practices, such as regular lid scrubs, play a crucial role in preventing recurrence and maintaining meibomian gland health. A clinician should consider referral to an ophthalmologist if the chalazion is causing visual disturbance, persists despite appropriate conservative management for several weeks, raises suspicion for malignancy (e.g., rapid growth, atypical features), or if the clinician is uncertain about the diagnosis. Learn more about the latest guidelines for chalazion management to ensure you're providing the most effective and up-to-date care. Consider implementing a staged management approach, starting with conservative measures and escalating to surgical intervention or referral as needed.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.